Articles

Innovative therapies scale up to meet needs of a growing patient population

Patient age is significant in the long-term effect of orthokeratology lenses

Optical coherence tomography angiography could also identify patients at risk of disease progression

The company made its CE Mark announcement during the ESCRS Winter Meeting

Physicians explore how other specialties adopt and integrate remote monitoring

The Phase 2/3 VISTA trial for AGTC-501 in XLRP is expected to begin in in the first half of 2024

The company, headquarted in New York and London, named OK-101 as the first IND clearance granted by the FDA for a drug to begin clinical studies specifically to treat NCP

The technology has potential for applications in contact lenses and intraocular implants

According to the company, the patent further protects Iridex’s intellectual property encompassing laser systems in ophthalmology and related fields

An investment from the Sir Jules Thorn Charitable Trust will support a state-of-the-art building, opening in 2027

Toku’s AI technology, CLAiR, provides fast, accurate, non-invasive cardiovascular disease (CVD) risk assessments using standard retinal images

How this treatment paradigm could change ocular cell therapy

Dr Baruch Kuppermann discusses interim results from the first in-human Phase 2 RIPPLE-1 Trial of a dexamethasone implant for diabetic macular oedema and retinal vein occlusion.

Robyn Guymer, MBBS, PhD, reported the Voyager study’s preliminary data at the 2024 Angiogenesis, Exudation, and Degeneration conference

EODM may be an ideal candidate for development of complement gene therapy due to the high-impact genetic variants

Researchers aimed to develop a translational map to understand how advanced imaging biomarkers manifest in typical diagnostic imaging

Kiora Pharmaceuticals and Théa Open Innovation will develop and commercialise KIO-301 for the treatment of inherited retinal diseases

Many options with one single Nd:YAG laser

Enhanced detection and diagnosis of common and severe diseases

An in-depth case study conversation

Standalone, minimally-invasive glaucoma treatments

The afternoon sessions begin after lunch and continue well into the evening at the Angiogenesis, Exudation, and Degeneration 2024 meeting

The one-day event will be held online Saturday, February 3, 2024, and is sponsored by the Bascom Palmer Eye Institute, University of Miami Health System

The partnership establishes a large-scale enrollment platform for research on MicroPulseTransscleral Laser Therapy (TLT)

Postoperative outcomes of the tissues obtained from these donors were satisfactory

Investigators advised that further studies should be conducted to understand more precisely the benefits and risks

Clinicians, researchers and stakeholders discussed establishing CVI diagnostic criteria, boosting awareness of CVI and creating a participant data registry

Euan Thomson, Head of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit at Carl Zeiss Meditec, discusses plans for the company's vitreoretinal surgery workflows following announcement of DORC acquisition

A strategic distribution partnership is expected to make Morrow’s eProgressive smart glasses available to consumers in the second quarter of 2024